series-a
Stage
1
Investors
About
Freespira develops an FDA-cleared, medication-free digital therapeutic device and program that delivers a 28-day treatment to reduce or eliminate symptoms of panic disorder, panic attacks, and post-traumatic stress disorder, used by health plans, providers, and employers.
Explore Freespira's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.